Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival
2 vistas
• 07/10/23
0
0
Empotrar
administrator
Suscriptores
The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios